ITRM970390A0 - - Google Patents
Info
- Publication number
- ITRM970390A0 ITRM970390A0 ITRM970390A ITRM970390A ITRM970390A0 IT RM970390 A0 ITRM970390 A0 IT RM970390A0 IT RM970390 A ITRM970390 A IT RM970390A IT RM970390 A ITRM970390 A IT RM970390A IT RM970390 A0 ITRM970390 A0 IT RM970390A0
- Authority
- IT
- Italy
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97RM000390A IT1293067B1 (it) | 1997-07-01 | 1997-07-01 | Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico |
| EP98929631A EP0983066A1 (en) | 1997-07-01 | 1998-06-18 | Pharmaceutical composition comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| NZ501844A NZ501844A (en) | 1997-07-01 | 1998-06-18 | Alkanoyl L-carnitine in combination with a statin (simvastatin, lovastatin, provastatin or fluvastatin) for treating abnormal lipid metabolism disorders |
| AU79310/98A AU726822B2 (en) | 1997-07-01 | 1998-06-18 | Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| CA002295748A CA2295748A1 (en) | 1997-07-01 | 1998-06-18 | Pharmaceutical compositions comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| PCT/IT1998/000163 WO1999001126A1 (en) | 1997-07-01 | 1998-06-18 | Pharmaceutical compositions comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| KR10-1999-7012633A KR100539066B1 (ko) | 1997-07-01 | 1998-06-18 | 비정상적 지질대사-유래 질환치료에 유용한 스타틴과알카노일 ｌ-카르니틴 함유 약제 조성물 |
| EP05105620A EP1623708A3 (en) | 1997-07-01 | 1998-06-18 | Pharmaceutical composition comprising acetyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| JP50684499A JP2002507223A (ja) | 1997-07-01 | 1998-06-18 | 脂質代謝異常によりもたらされる疾患の治療のための、アルカノイルｌ−カルニチンをスタチンと組み合わせて含む医薬組成物 |
| US09/446,806 US6180680B1 (en) | 1997-07-01 | 1998-06-18 | Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| IL13349298A IL133492A (en) | 1997-07-01 | 1998-06-18 | Pharmaceutical preparations containing alkanol L - carnitine in combination with a statin for the treatment of diseases caused by a change in lipid metabolism |
| US10/928,156 US20050026846A1 (en) | 1997-01-07 | 2004-08-30 | Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97RM000390A IT1293067B1 (it) | 1997-07-01 | 1997-07-01 | Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITRM970390A0 true ITRM970390A0 (US06559137-20030506-C00182.png) | 1997-07-01 |
| ITRM970390A1 ITRM970390A1 (it) | 1999-01-01 |
| IT1293067B1 IT1293067B1 (it) | 1999-02-11 |
Family
ID=11405149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT97RM000390A IT1293067B1 (it) | 1997-01-07 | 1997-07-01 | Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico |
Country Status (10)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1064943B1 (en) * | 1999-06-30 | 2005-02-09 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Combination having antilipemic activity substantially free from toxic or side effects due to antilipemic drugs |
| HUP0201597A3 (en) * | 1999-06-08 | 2003-04-28 | Sigma Tau Ind Farmaceutiche S | Antilipemic combunations comprising hmg-coa reductase inhibitors and carnitines |
| US6245800B1 (en) * | 1999-06-08 | 2001-06-12 | Sigma-Tau | Method of preventing or treating statin-induced toxic effects using L-carnitine or an alkanoyl L-carnitine |
| US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
| ITRM20040307A1 (it) | 2004-06-23 | 2004-09-23 | Sigma Tau Ind Farmaceuti | Confezione per almeno due prodotti differenti da vendere e utilizzare insieme. |
| EA016855B1 (ru) * | 2007-02-27 | 2012-08-30 | Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. | Применение l-карнитина и/или алканоил l-карнитина в комбинации со статином для лечения диабета 2 типа |
| SG10201507488RA (en) * | 2007-03-21 | 2015-10-29 | Sigma Tau Ind Farmaceuti | Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| MX2010009290A (es) * | 2008-02-29 | 2010-09-14 | Biolab Sanus Farmaceutica Ltda | Composicion farmaceutica. |
| US11591288B2 (en) | 2017-08-23 | 2023-02-28 | Gavish-Galilee Bio Applications Ltd. | Compositions and methods for treating atherosclerotic cardiovascular disease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2903579A1 (de) * | 1978-02-03 | 1979-08-09 | Sigma Tau Ind Farmaceuti | Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel |
-
1997
- 1997-07-01 IT IT97RM000390A patent/IT1293067B1/it active IP Right Grant
-
1998
- 1998-06-18 AU AU79310/98A patent/AU726822B2/en not_active Ceased
- 1998-06-18 EP EP98929631A patent/EP0983066A1/en not_active Ceased
- 1998-06-18 EP EP05105620A patent/EP1623708A3/en not_active Withdrawn
- 1998-06-18 US US09/446,806 patent/US6180680B1/en not_active Expired - Fee Related
- 1998-06-18 IL IL13349298A patent/IL133492A/en not_active IP Right Cessation
- 1998-06-18 NZ NZ501844A patent/NZ501844A/en not_active IP Right Cessation
- 1998-06-18 KR KR10-1999-7012633A patent/KR100539066B1/ko not_active IP Right Cessation
- 1998-06-18 WO PCT/IT1998/000163 patent/WO1999001126A1/en active IP Right Grant
- 1998-06-18 JP JP50684499A patent/JP2002507223A/ja not_active Ceased
- 1998-06-18 CA CA002295748A patent/CA2295748A1/en not_active Abandoned
-
2004
- 2004-08-30 US US10/928,156 patent/US20050026846A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20050026846A1 (en) | 2005-02-03 |
| IL133492A (en) | 2004-07-25 |
| AU726822B2 (en) | 2000-11-23 |
| WO1999001126A1 (en) | 1999-01-14 |
| EP0983066A1 (en) | 2000-03-08 |
| IL133492A0 (en) | 2001-04-30 |
| AU7931098A (en) | 1999-01-25 |
| CA2295748A1 (en) | 1999-01-14 |
| US6180680B1 (en) | 2001-01-30 |
| ITRM970390A1 (it) | 1999-01-01 |
| JP2002507223A (ja) | 2002-03-05 |
| NZ501844A (en) | 2001-10-26 |
| IT1293067B1 (it) | 1999-02-11 |
| KR100539066B1 (ko) | 2005-12-26 |
| EP1623708A3 (en) | 2006-02-15 |
| KR20010014439A (ko) | 2001-02-26 |
| EP1623708A2 (en) | 2006-02-08 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted |